Merck KGaA

Company Snapshot

Founded: 1668
Entity Type: Public
Employees: 62,557
Region: Asia-Pacific
Revenue: $22,895.3 Millions
Revenue Year: 2024
Segment: Life Science
Headquarter: Darmstadt, Germany
Key Geographics: Europe, North America, Latin America, Middle East & Africa, Asia-Pacific
Corporate Address: Frankfurter Strasse 250 Darmstadt, 64293, Germany Tel. +49-615-1720 www.merckgroup.com

Company Overview

Merck KGaA, with its headquarters in Darmstadt, Germany, is a science and technology leader operating in Healthcare, Life Science, and Electronics. Founded in 1668, it is the world's oldest pharmaceutical and chemical company, with operations in more than 65 countries and approximately 62,000 employees.

The Healthcare division develops innovative therapies, the Life Science segment provides tools and services for scientific research, and the Electronics division supplies advanced materials for digital technologies. The company is owned by the Merck family through 70.3% ownership, while the company operates under the name "EMD" in the United States and Canada due to differences in trademark.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Merck KGaA In Reports

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Our detailed report on the Central Nervous System Biomarkers Markets is segmented based on by biomarker type, technology, disease, application, and region for the forecast 2025 through 2030.

3D Protein Structure Analysis: Global Markets

BCC Research detailed report on 3D Protein Structure Analysis Market with data from 2024, estimates from 2025, projections of compound annual growth rates through 2030 (forecast period 2025 – 2030).

Cell and Gene Therapy Tools and Reagents: Global Markets

BCC Research detailed report on Cell and Gene Therapy Tools and Reagents Market covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). For market estimates, data has been provided for 2024 as...

Company's Business Segments

  • Life Science : Science & Lab Solutions, Process Solutions and Life Science Services
  • Healthcare : Oncology, Erbitux, Bavencio, Neurology & Immunology, Rebif, Mavenclad, Fertility, Gonal-f, Cardiovascular, Metabolism & Endocrinology
  • Electronics : Semiconductor Solutions, Display Solutions and Surface Solutions

Applications/End User Industries

  • Neurological Disorders
  • Immunological Diseases
  • Multiple Sclerosis
  • Reproductive Health And Fertility
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Endocrine Disorders
  • Scientific Research
  • Laboratory Work
  • Reagents
  • Semiconductor Manufacturing
  • Liquid Crystals
  • Automotive Electronics
  • Electronic Applications
  • Consumer Electronics
  • Filtration Systems
  • Contract Research
  • Process Development
  • Biopharmaceutical Manufacturing
  • Therapies For Cancer Treatment
  • Oncology
  • Neurology & Immunology
  • Fertility
  • Endocrinology
  • Pharma Biotech
  • Diagnostics
  • Government & Academic Research
  • Industrial
  • Semiconductor Solutions
  • Display Solutions
  • Surface Solutions
  • Advancing Digital Living with Electronics
  • Healthcare Pipeline
  • Clinical Trials
  • Global R&D Hubs
  • Artificial Intelligence - AI Research
  • Global Health Institute
AI Sentiment